期刊文献+

超声引导下微波消融应用于皮下软组织恶性转移瘤的疗效评估

Evaluation of Ultrasound-Guided Microwave Ablation in Subcutaneous Soft Tissue Malignant Metastasis
下载PDF
导出
摘要 目的:探讨超声引导下微波消融(MWA)治疗皮下软组织恶性转移瘤的疗效。方法:回顾性分析确诊为皮下软组织恶性转移瘤并行超声引导下MWA治疗的50例患者的病历资料,原发性肿瘤均已稳定控制。要求患者术后规律随访,记录患者术后并发生及复发、转移发生情况,并评估术后随访期微波消融术消融区吸收疗效。结果:不同直径患者完全消融率比较差异有统计学意义(P 0.05),24月复发率与转移率分别为20%、28%。在术后24月的随访过程中,结节的体积由5.62 ±14.36 cm3减小至0.01 ±0.04 cm3 (P 【0.05),24月完全吸收率达76%。结论:超声引导下MWA对治疗皮下软组织恶性转移瘤效果可观,具有操作简单、实时监测、并发症少等优点;对于不宜行外科手术的患者,超声引导下MWA不失为一种较安全、有效的替代外科手术的治疗方法。 Objective: To evaluate the efficacy of ultrasound-guided microwave ablation (MWA) in the treatment of subcutaneous soft tissue malignant metastasis. Methods: The medical records of 50 patients with subcutaneous soft tissue malignant metastasis treated with ultrasound-guided MWA were analyzed. Primary tumors had been stably controlled. Patients were required to follow up regularly after MWA, record the complications, recurrence and metastases of patients after MWA, and evaluate the absorption effect of microwave ablation area during postoperative follow-up. Results: There was significant difference in complete ablation rate among patients with different diameters (P 0.05). The 24-month recurrence rate and metastases rate were 20% and 28% respectively. During the follow-up of 24 months after MWA, the volume of nodules decreased from 5.62 ±14.36 cm3 to 0.01 ±0.04 cm3 (P <0.05), and the complete absorption rate was 76%. Conclusion: Ultrasound-guided MWA is effective in the treatment of subcutaneous soft tissue malignant metastasis. It has the advantages of simple operation, real-time monitoring and less complications. For patients who are not suitable for surgery, ultrasound-guided MWA is a safe and effective alternative therapy.
出处 《临床医学进展》 2021年第9期4216-4221,共6页 Advances in Clinical Medicine
  • 相关文献

参考文献5

二级参考文献27

  • 1Weiss SW, Goldblum JR. Enzinger and Weiss' Soft Tissue Tumors [ M]. 5th ed. New York :Mosbby elsevier,2008.
  • 2Fletcher CD, Organization WH, Cancer IAFRO. WHO Classifica- tion of Tumours of Soft Tissue and Bone ( IARC WHO Classifica- tion of Tumours [ M ]. 4th ed, Lyon : IARC press ,2013.
  • 3Nojima T. The pathologic diagnosis of bone and soft tissue tumors : update [ J ]. Rinsho Byori ,2014,62 (6) :578-585.
  • 4Wong JC, Abraham JA. Upper extremity considerations for onco- logic surgery [ J ]. Orthop Clin North Am, 2014,45 ( 4 ) : 541-564.
  • 5Sluijmer HC, Becker SJ, Bossen JK, et al. Excisional biopsy of sus- pected benign soft tissue tumors of the upper extremity : correlation between preoperative diagnosis and actual pathology[ J]. Hand (N Y) , 2014,9(3) :351-355.
  • 6Amino K, Kawaguchi N, Matsumoto S, et al. Surgical treatment of malignant soft tissue tumors[ J]. Gan To Kagaku Ryoho, 1987,14 (5 Pt 2) :1589,1596.
  • 7Gronchi A1, Colombo C, Raut CP. Surgical management of local- ized soft tissue tumors[ J]. Cancer,2014,120(17) :2638-2648.
  • 8Pap DP, Mayerson JL, Scharschmidt TJ. Soft tissue tumor recur- rence after intramedullary stabilization of impending pathologic fractures[ J]. Orthopedics ,2012,35 ( 3 ) : e448-452.
  • 9Kang S, Han I, Kim S, et al. Outcomes after flap reconstruction for extremity soft tissue sarcoma: a case-control study using pro- pensity score analysis [ J ]. Eur J Surg Oncol, 2014, 40 ( 9 ) : 1101-1108. Kw.
  • 10ong TN, Furtado S, Gerrand C. What do we know about sur- vivorship after treatment for extremity sarcoma A systematic review [J]. Eur J Surg 0ncol,2014,40(9) :1109-1124.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部